Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-10 Sale |
2021-03-12 8:00 pm |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
1,048 | $34.95 | $36,631 | 92,854 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-01 Option Award |
2025-01-03 5:34 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director |
24,000 | $0 | 25,730 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:33 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director |
3,882 | $0 | 25,960 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:30 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
74 | $13.94 | 36,407 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:03 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director |
2,000 | $0 | 22,078 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-10 8:03 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director |
4,216 | $0 | 20,078 (Direct) |
View |
| 2021-08-31 Exercise |
2021-09-02 8:00 pm |
N/A 2028-12-11 |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
4,900 | $0 | 113,933 (Direct) |
View |
| 2021-08-31 Exercise |
2021-09-02 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
4,900 | $15 | 113,933 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
454 | $29.49 | 31,433 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
2,500 | $0 | 92,854 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 8:00 pm |
N/A 2031-03-09 |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
56,875 | $0 | 92,854 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 5:06 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
48 | $30.92 | 29,527 (Direct) |
View |
| 2020-07-02 Option Award |
2020-07-06 7:44 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
488 | $30.66 | 29,479 (Direct) |
View |